A detailed history of Coldstream Capital Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Coldstream Capital Management Inc holds 26,777 shares of AZN stock, worth $1.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
26,777
Previous 25,727 4.08%
Holding current value
$1.78 Million
Previous $2.01 Million 3.99%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$76.67 - $87.62 $80,503 - $92,001
1,050 Added 4.08%
26,777 $2.09 Million
Q2 2024

Aug 07, 2024

BUY
$66.81 - $80.83 $741,724 - $897,374
11,102 Added 75.91%
25,727 $2.01 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $200,117 - $228,120
3,279 Added 28.9%
14,625 $990,000
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $155,529 - $174,100
2,513 Added 28.45%
11,346 $764,000
Q3 2023

Nov 02, 2023

BUY
$64.85 - $71.7 $55,511 - $61,375
856 Added 10.73%
8,833 $598,000
Q2 2023

Aug 03, 2023

BUY
$69.91 - $75.81 $1,188 - $1,288
17 Added 0.21%
7,977 $570,000
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $4,231 - $4,797
67 Added 0.85%
7,960 $552,000
Q4 2022

Jan 10, 2023

BUY
$54.21 - $70.44 $129,345 - $168,069
2,386 Added 43.33%
7,893 $0
Q2 2022

Aug 08, 2022

BUY
$59.26 - $71.14 $326,344 - $391,767
5,507 New
5,507 $364,000
Q2 2022

Aug 08, 2022

SELL
$59.26 - $71.14 $237,158 - $284,702
-4,002 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$55.72 - $67.12 $91,882 - $110,680
-1,649 Reduced 29.18%
4,002 $265,000
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $305,267 - $360,703
5,651 New
5,651 $329,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.